You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nicotinamide Mononucleotide (NMN)

Showing 1 - 25 of 179
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial in Dijon (Nicotinamide mononucleotide (NMN-C))

Completed
  • Healthy Volunteers
  • Nicotinamide mononucleotide (NMN-C)
  • Dijon, France
    Biomed 21
Jan 25, 2023

Healthy Volunteers Trial in Toronto (Nicotinamide mononucleotide (NMN-C))

Active, not recruiting
  • Healthy Volunteers
  • Nicotinamide mononucleotide (NMN-C)
  • Toronto, Ontario, Canada
    Vitalabs Clinic
May 31, 2022

Glucose Metabolism Disorders Trial in Saint Louis (Placebo, Treatment)

Recruiting
  • Glucose Metabolism Disorders
  • Placebo
  • Treatment
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 6, 2022

Enhance Immune Function Trial (NMN)

Not yet recruiting
  • Enhance Immune Function
  • (no location specified)
Aug 2, 2023

Postoperative Prevention of Tumor Trial in Shanghai (Oral NMN combined with DC cell vaccine)

Not yet recruiting
  • Postoperative Prevention of Tumor
  • Oral NMN combined with DC cell vaccine
  • Shanghai, Shanghai, China
    Shanghai Mengchao Cancer Hospital
Sep 6, 2023

Polycystic Ovary Syndrome Trial in Beijing (NMN intervention, Placebo)

Recruiting
  • Polycystic Ovary Syndrome
  • NMN intervention
  • Placebo
  • Beijing, China
    Peking University Third Hospital
Jun 20, 2022

Binge Drinking, Liver Injury, Nutritional Supplementation Trial in Hangzhou (ß-nicotinamide Mononucleotide, Maltodextrin)

Not yet recruiting
  • Binge Drinking
  • +3 more
  • β-nicotinamide Mononucleotide
  • Maltodextrin
  • Hangzhou, Zhejiang, China
    Zhejiang Chinese Medical University
May 19, 2023

Diminished Ovarian Reserve, Premature Ovarian Insufficiency Trial in Beijing (NMN intervention, Placebo)

Not yet recruiting
  • Diminished Ovarian Reserve
  • Premature Ovarian Insufficiency
  • NMN intervention
  • Placebo
  • Beijing, Beijing, China
    Peking University Third Hospital
Aug 2, 2022

COVID-19 Infection Trial in India (Nicotinamide Mononucleotide, Nicotinamide Mononucleotide with L-Leucine, Placebo)

Recruiting
  • COVID-19 Infection
  • Nicotinamide Mononucleotide
  • +2 more
  • Vadodara, Gujarat, India
  • +11 more
Feb 16, 2022

Glucose Metabolism Disorders Trial in Saint Louis (NMN supplement, Placebo)

Completed
  • Glucose Metabolism Disorders
  • NMN supplement
  • Placebo
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 13, 2021

Physical Activity, Muscle Recovery Trial in Dijon (Nicotinamide mononucleotide, Placebo)

Recruiting
  • Physical Activity
  • Muscle Recovery
  • Nicotinamide mononucleotide
  • Placebo
  • Dijon, France
    CEN Nutriment
May 31, 2022

Healthy Trial in Bergen (nicotinamide riboside, nicotinamide mononucleotide)

Recruiting
  • Healthy
  • nicotinamide riboside
  • nicotinamide mononucleotide
  • Bergen, Vestland, Norway
    Haukeland University Hospital
Jan 25, 2023

Aging Trial in Pune (Nicotinamide Mononucleotide, Placebo)

Completed
  • Aging
  • Nicotinamide Mononucleotide
  • Placebo
  • Pune, Maharashtra, India
  • +1 more
Sep 30, 2021

Aging Trial in Pune (NMN, Placebo)

Completed
  • Aging
  • NMN
  • Placebo
  • Pune, Maharashtra, India
  • +1 more
Mar 30, 2021

Hypertension Trial in Guangzhou (Nicotinamide mononucleotide supplied as 400mg capsule, Lifestyle modification)

Recruiting
  • Hypertension
  • Nicotinamide mononucleotide supplied as 400mg capsule
  • Lifestyle modification
  • Guangzhou, Guangdong, China
    First Affiliated Hospital,Sun Yat-sen University
Jan 17, 2022

Healthy Trial (Investigational Product - MIB 626, Placebo, Standardized, progressive, high intensity, multidimensional exercise)

Not yet recruiting
  • Healthy
  • Investigational Product - MIB 626
  • +3 more
  • (no location specified)
Jun 1, 2023

Type2diabetes, Diabetic Kidney Disease Trial (Investigational Product - MIB 626, Placebo)

Not yet recruiting
  • Type2diabetes
  • Diabetic Kidney Disease
  • Investigational Product - MIB 626
  • Placebo
  • (no location specified)
Mar 6, 2023

AKI Trial in Rochester (Nicotinamide Riboside + Pterostilbene, Placebo)

Recruiting
  • AKI
  • Nicotinamide Riboside + Pterostilbene
  • Placebo
  • Rochester, Minnesota
    Mayo Clinic
Feb 9, 2022

Sickle Cell Disease Trial in Marseille (NUV001)

Not yet recruiting
  • Sickle Cell Disease
  • NUV001
  • Marseille, France
    Aphm Hopital La Timone Adultes Sce Medecine Interne (Umap)
Mar 28, 2023

Healthy Trial in Poznan (Cardio-pulmonary exercise test)

Completed
  • Healthy
  • Cardio-pulmonary exercise test
  • Poznań, Poland
    Poznan University of Physical Education
Nov 10, 2021

Chemo-induced Peripheral Neuropathy, Breast Cancer Metastatic, Platinum-resistant Recurrent Ovarian Cancer Trial in Iowa City,

Recruiting
  • Chemotherapy-induced Peripheral Neuropathy
  • +2 more
  • Nicotinamide Riboside
  • Iowa City, Iowa
  • +1 more
Apr 26, 2021

Hypertension Trial in London (Limitless)

Recruiting
  • Hypertension
  • Limitless
  • London, Ontario, Canada
    KGK Science Inc.
Mar 17, 2022

NAD Trial in Berlin (Niagen, Placebo)

Not yet recruiting
  • NAD
  • Niagen
  • Placebo
  • Berlin, Germany
    Surgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte,
Aug 22, 2023

Investigate eNAMPT in Multiple Myeloma Biology and Establish Its

Recruiting
  • Multiple Myeloma
    • Torino, TO, Italy
      Aou Citta' Della Salute E Della Scienza Di Torino
    Aug 17, 2021

    Hypertension, Aging Trial in Boulder (Nicotinamide riboside, Placebo)

    Recruiting
    • Hypertension
    • Aging
    • Nicotinamide riboside
    • Placebo
    • Boulder, Colorado
      Integrative Physiology of Aging Laboratory
    Feb 14, 2022